Susanne B Breitkopf1,2, Stéphane J H Ricoult3, Min Yuan1, Ying Xu1, David A Peake4, Brendan D Manning3, John M Asara1,2. 1. Division of Signal Transduction/Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. 2. Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. 3. Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA. 4. Thermo Fisher Scientific, 355 River Oaks Pkwy, San Jose, CA 95134, USA.
Abstract
INTRODUCTION: Advances in high-resolution mass spectrometry have created renewed interest for studying global lipid biochemistry in disease and biological systems. OBJECTIVES: Here, we present an untargeted 30 min. LC-MS/MS platform that utilizes positive/negative polarity switching to perform unbiased data dependent acquisitions (DDA) via higher energy collisional dissociation (HCD) fragmentation to profile more than 1000-1500 lipid ions mainly from methyl-tert-butyl ether (MTBE) or chloroform:methanol extractions. METHODS: The platform uses C18 reversed-phase chromatography coupled to a hybrid QExactive Plus/HF Orbitrap mass spectrometer and the entire procedure takes ~10 h from lipid extraction to identification/quantification for a data set containing 12 samples (~4 h for a single sample). Lipids are identified by both accurate precursor ion mass and fragmentation features and quantified using Lipid-Search and Elements software. RESULTS: Using this approach, we are able to profile intact lipid ions from up to 18 different main lipid classes and 66 subclasses. We show several studies from different biological sources, including cultured cancer cells, resected tissues from mice such as lung and breast tumors and biological fluids such as plasma and urine. CONCLUSIONS: Using mouse embryonic fibroblasts, we showed that TSC2-/- KD significantly abrogates lipid biosynthesis and that rapamycin can rescue triglyceride (TG) lipids and we show that SREBP-/- shuts down lipid biosynthesis significantly via mTORC1 signaling pathways. We show that in mouse EGFR driven lung tumors, a large number of TGs and phosphatidylmethanol (PMe) lipids are elevated while some phospholipids (PLs) show some of the largest decrease in lipid levels from ~ 2000 identified lipid ions. In addition, we identified more than 1500 unique lipid species from human blood plasma.
INTRODUCTION: Advances in high-resolution mass spectrometry have created renewed interest for studying global lipid biochemistry in disease and biological systems. OBJECTIVES: Here, we present an untargeted 30 min. LC-MS/MS platform that utilizes positive/negative polarity switching to perform unbiased data dependent acquisitions (DDA) via higher energy collisional dissociation (HCD) fragmentation to profile more than 1000-1500 lipid ions mainly from methyl-tert-butyl ether (MTBE) or chloroform:methanol extractions. METHODS: The platform uses C18 reversed-phase chromatography coupled to a hybrid QExactive Plus/HF Orbitrap mass spectrometer and the entire procedure takes ~10 h from lipid extraction to identification/quantification for a data set containing 12 samples (~4 h for a single sample). Lipids are identified by both accurate precursor ion mass and fragmentation features and quantified using Lipid-Search and Elements software. RESULTS: Using this approach, we are able to profile intact lipid ions from up to 18 different main lipid classes and 66 subclasses. We show several studies from different biological sources, including cultured cancer cells, resected tissues from mice such as lung and breast tumors and biological fluids such as plasma and urine. CONCLUSIONS: Using mouse embryonic fibroblasts, we showed that TSC2-/- KD significantly abrogates lipid biosynthesis and that rapamycin can rescue triglyceride (TG) lipids and we show that SREBP-/- shuts down lipid biosynthesis significantly via mTORC1 signaling pathways. We show that in mouseEGFR driven lung tumors, a large number of TGs and phosphatidylmethanol (PMe) lipids are elevated while some phospholipids (PLs) show some of the largest decrease in lipid levels from ~ 2000 identified lipid ions. In addition, we identified more than 1500 unique lipid species from human blood plasma.
Authors: Dominik Schwudke; Kai Schuhmann; Ronny Herzog; Stefan R Bornstein; Andrej Shevchenko Journal: Cold Spring Harb Perspect Biol Date: 2011-09-01 Impact factor: 10.005
Authors: Kendra J Adams; Brian Pratt; Neelanjan Bose; Laura G Dubois; Lisa St John-Williams; Kevin M Perrott; Karina Ky; Pankaj Kapahi; Vagisha Sharma; Michael J MacCoss; M Arthur Moseley; Carol A Colton; Brendan X MacLean; Birgit Schilling; J Will Thompson Journal: J Proteome Res Date: 2020-03-26 Impact factor: 4.466
Authors: Susanne B Breitkopf; Stéphane J H Ricoult; Min Yuan; Ying Xu; David A Peake; Brendan D Manning; John M Asara Journal: Metabolomics Date: 2017-02-07 Impact factor: 4.290
Authors: Min Yuan; Daniel M Kremer; He Huang; Susanne B Breitkopf; Issam Ben-Sahra; Brendan D Manning; Costas A Lyssiotis; John M Asara Journal: Nat Protoc Date: 2019-02 Impact factor: 13.491
Authors: Daniel R Schmidt; Rutulkumar Patel; David G Kirsch; Caroline A Lewis; Matthew G Vander Heiden; Jason W Locasale Journal: CA Cancer J Clin Date: 2021-05-13 Impact factor: 286.130
Authors: Andrii Kovalenko; Andres Sanin; Kosmas Kosmas; Long Zhang; Ji Wang; Elie W Akl; Krinio Giannikou; Clemens K Probst; Thomas R Hougard; Ryan W Rue; Vera P Krymskaya; John M Asara; Hilaire C Lam; David J Kwiatkowski; Elizabeth P Henske; Harilaos Filippakis Journal: Cancer Res Date: 2021-02-16 Impact factor: 13.312
Authors: John A Bowden; Alan Heckert; Candice Z Ulmer; Christina M Jones; Jeremy P Koelmel; Laila Abdullah; Linda Ahonen; Yazen Alnouti; Aaron M Armando; John M Asara; Takeshi Bamba; John R Barr; Jonas Bergquist; Christoph H Borchers; Joost Brandsma; Susanne B Breitkopf; Tomas Cajka; Amaury Cazenave-Gassiot; Antonio Checa; Michelle A Cinel; Romain A Colas; Serge Cremers; Edward A Dennis; James E Evans; Alexander Fauland; Oliver Fiehn; Michael S Gardner; Timothy J Garrett; Katherine H Gotlinger; Jun Han; Yingying Huang; Aveline Huipeng Neo; Tuulia Hyötyläinen; Yoshihiro Izumi; Hongfeng Jiang; Houli Jiang; Jiang Jiang; Maureen Kachman; Reiko Kiyonami; Kristaps Klavins; Christian Klose; Harald C Köfeler; Johan Kolmert; Therese Koal; Grielof Koster; Zsuzsanna Kuklenyik; Irwin J Kurland; Michael Leadley; Karen Lin; Krishna Rao Maddipati; Danielle McDougall; Peter J Meikle; Natalie A Mellett; Cian Monnin; M Arthur Moseley; Renu Nandakumar; Matej Oresic; Rainey Patterson; David Peake; Jason S Pierce; Martin Post; Anthony D Postle; Rebecca Pugh; Yunping Qiu; Oswald Quehenberger; Parsram Ramrup; Jon Rees; Barbara Rembiesa; Denis Reynaud; Mary R Roth; Susanne Sales; Kai Schuhmann; Michal Laniado Schwartzman; Charles N Serhan; Andrej Shevchenko; Stephen E Somerville; Lisa St John-Williams; Michal A Surma; Hiroaki Takeda; Rhishikesh Thakare; J Will Thompson; Federico Torta; Alexander Triebl; Martin Trötzmüller; S J Kumari Ubhayasekera; Dajana Vuckovic; Jacquelyn M Weir; Ruth Welti; Markus R Wenk; Craig E Wheelock; Libin Yao; Min Yuan; Xueqing Heather Zhao; Senlin Zhou Journal: J Lipid Res Date: 2017-10-06 Impact factor: 5.922